Physicians now have the luxury of focusing attention on maximizing outcomes that are already quite favorable, and of devoting more attention to improving quality of life and addressing questions of cost-effectiveness.
Neil P. Shah, MD, PhD
Advertisement
Articles by Neil P. Shah, MD, PhD
Advertisement
Latest Updated Articles
- Front-Line TKI Therapy for Chronic-Phase CML: the Luxury of Choice
Published: October 12th 2012 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
ESMO 2025: The Top 10 Takeaways That May Shift Oncology Practice
2
Convergent and Divergent Signaling Pathways in Cancer: A Dual-Axis Model for Adaptive Precision Oncology
3
FDA Approves Revumenib in R/R NPM1-Mutant AML
4
ctDNA Status May Determine Adjuvant Immunotherapy Benefit in MIBC
5
